What is the significance of an elevated DHEA‑sulfate level of 716 µg/dL and how should it be evaluated?

Elevated DHEA-Sulfate 716 µg/dL: Clinical Significance and Evaluation

A DHEA-S level of 716 µg/dL requires urgent evaluation to exclude an adrenal tumor, as levels exceeding 600 µg/dL are highly suspicious for adrenal neoplasm. 1

Immediate Diagnostic Priorities

Rule Out Adrenal Tumor (Most Critical)

DHEA-S >600 µg/dL is the threshold that raises concern for adrenal adenoma or carcinoma. 1 Your level of 716 µg/dL crosses this critical threshold and mandates:

• Abdominal CT scan without contrast (measure Hounsfield units <10 HU suggests benign adenoma) 2
• If mass identified >4 cm or irregular margins: high suspicion for adrenal carcinoma requiring open adrenalectomy 2
• Assess for virilization signs: clitoral hypertrophy, deepening voice, male pattern baldness, severe hirsutism 3

Additional Hormonal Assessment

Complete the following to characterize the hyperandrogenic state:

• 8 AM total testosterone (if >2x upper normal limit, strongly suggests tumor) 4
• 17-hydroxyprogesterone (screen for nonclassic congenital adrenal hyperplasia) 1
• 24-hour urinary free cortisol or 1-mg overnight dexamethasone suppression test (exclude Cushing syndrome, especially if DHEA-S elevation is tumor-related) 1, 5
• Free testosterone or FAI if total testosterone normal but clinical hyperandrogenism present 6, 7

Differential Diagnosis Algorithm

If Imaging Shows Adrenal Mass:

• Mass >4 cm or irregular: Presume malignancy → open adrenalectomy 2
• Mass <4 cm, homogeneous, <10 HU: Likely benign adenoma → consider laparoscopic adrenalectomy if hormonally active 2
• Rule out pheochromocytoma biochemically before any adrenal surgery 2

If No Adrenal Mass Identified:

DHEA-S 600-800 µg/dL range without tumor suggests:

1. PCOS with prominent adrenal component (most common if reproductive-age female with oligomenorrhea, hirsutism) 1, 3

   • Expect: LH>FSH, high-normal testosterone, possible FAI elevation
   • Adrenal androgens higher in normal-weight vs. overweight PCOS patients 1

2. Nonclassic CAH (particularly if Ashkenazi Jewish, Hispanic, or Slavic ethnicity) 6

   • 17-OHP >200 ng/dL (morning, follicular phase) warrants ACTH stimulation test
   • Post-ACTH 17-OHP >1000 ng/dL confirms diagnosis 3

3. Early ACTH-secreting pituitary microadenoma (rare but important) 8

   • Consider if DHEA-S elevation precedes cortisol abnormalities
   • May require serial MRI if initial imaging negative

Common Pitfalls to Avoid

• Do not dismiss levels 600-800 µg/dL as "mildly elevated" – this range demands tumor exclusion 1
• Do not rely solely on testosterone – DHEA-S can be elevated with normal testosterone in adrenal-predominant hyperandrogenism 3
• Do not skip imaging – even without virilization, tumors can present with isolated DHEA-S elevation 3
• Verify assay method – immunoassays may have cross-reactivity; LC-MS/MS preferred for confirmation if available 4, 9

Functional Testing if Diagnosis Unclear

Two-day dexamethasone suppression test (0.5 mg every 6 hours × 8 doses): 3

• DHEA-S suppression >60% → adrenal source, likely functional
• DHEA-S suppression <60% with cortisol suppression → combined ovarian-adrenal or tumor
• No cortisol suppression → Cushing syndrome or adrenal carcinoma

Age and Gender Considerations

• Premenopausal women: PCOS most common if no tumor, but always exclude neoplasm first 3, 6
• Postmenopausal women or men: Tumor probability increases significantly with this DHEA-S level 10
• Rapid onset symptoms: Strongly suggests neoplasm regardless of age 3

The key message: DHEA-S of 716 µg/dL sits in a critical zone where adrenal imaging is non-negotiable, and tumor exclusion takes absolute priority over other diagnostic considerations.